CHD4 and colorectal carcinoma: In this study, we aimed to clarify the role of CHD4 in CRC, to explore the feasibility of using CHD4 as a prognostic biomarker in CRC patients, and to elucidate whether CHD4 could be a target for future anticancer drug development for CRC patients.